{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:17Z","timestamp":1786985417131,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004629","name":"Ministry for Business Innovation and Employment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004629","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bmc.2020.115837","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T21:33:28Z","timestamp":1604612008000},"page":"115837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["C-2 derivatized 8-sulfonamidoquinolines as antibacterial compounds"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9280-2742","authenticated-orcid":false,"given":"Emma K.","family":"Davison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7604-2870","authenticated-orcid":false,"given":"Freda F.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Young","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2622-9538","authenticated-orcid":false,"given":"Sonya","family":"Mros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichaela","family":"Harbison-Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essie M.","family":"Van Zuylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2093-8787","authenticated-orcid":false,"given":"Melanie K.","family":"Knottenbelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-7145","authenticated-orcid":false,"given":"Adam","family":"Heikal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7937-8273","authenticated-orcid":false,"given":"Scott A.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2598-534X","authenticated-orcid":false,"given":"Michelle A.","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2941-4197","authenticated-orcid":false,"given":"Woravimol","family":"Krittaphol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg F.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Brimble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rennison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2020.115837_b0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/00480169.2011.547165","article-title":"Economic aspects of mastitis: new developments","volume":"59","author":"Hogeveen","year":"2011","journal-title":"N Z Vet J."},{"key":"10.1016\/j.bmc.2020.115837_b0010","unstructured":"WHO Model Lists of Essential Medicines; https:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/. Accessed 13 July 2020."},{"key":"10.1016\/j.bmc.2020.115837_b0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2016.05.007","article-title":"8-Hydroxyquinolines in medicinal chemistry: A structural perspective","volume":"120","author":"Oliveri","year":"2016","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bmc.2020.115837_b0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1039\/C4MD00284A","article-title":"8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential","volume":"6","author":"Song","year":"2015","journal-title":"MedChemComm."},{"key":"10.1016\/j.bmc.2020.115837_b0025","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2147\/DDDT.S49763","article-title":"8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications","volume":"7","author":"Prachayasittikul","year":"2013","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.bmc.2020.115837_b0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2174\/0929867324666170518094404","article-title":"Repurposing of Copper(II)-chelating drugs for the treatment of neurodegenerative diseases","volume":"25","author":"Lanza","year":"2018","journal-title":"Curr Med Chem."},{"key":"10.1016\/j.bmc.2020.115837_b0035","doi-asserted-by":"crossref","first-page":"955","DOI":"10.4155\/fmc.12.32","article-title":"Modulating metals as a therapeutic strategy for Alzheimer's disease","volume":"4","author":"Hung","year":"2012","journal-title":"Future Med Chem."},{"key":"10.1016\/j.bmc.2020.115837_b0040","doi-asserted-by":"crossref","unstructured":"Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015;14(1): 39\u201347.","DOI":"10.1016\/S1474-4422(14)70262-5"},{"key":"10.1016\/j.bmc.2020.115837_b0045","doi-asserted-by":"crossref","unstructured":"Wilkins S, Masters CL, Bush AI, Cherny RA, DI F. Clioquinol protects against cell death in Parkinson\u2019s disease models in vivo and in vitro. In: Groenewegen H VP, Berendse H, Mulder A, Cools A., ed. The Basal Ganglia IX. Advances in Behavioral Biology. New York, NY: Springer; 2009: 431\u2013442.","DOI":"10.1007\/978-1-4419-0340-2_33"},{"key":"10.1016\/j.bmc.2020.115837_b0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00775-009-0594-5","article-title":"Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells","volume":"15","author":"Zhai","year":"2010","journal-title":"J Biol Inorg Chem."},{"key":"10.1016\/j.bmc.2020.115837_b0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/156800911794519770","article-title":"Clioquinol - a novel copper-dependent and independent proteasome inhibitor","volume":"11","author":"Schimmer","year":"2011","journal-title":"Curr Cancer Drug Targets."},{"key":"10.1016\/j.bmc.2020.115837_b0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/AAC.10.2.234","article-title":"Hydroxyquinolines inhibit ribonucleic acid-dependent deoxyribonucleic acid polymerase and inactivate Rous sarcoma virus and herpes simplex virus","volume":"10","author":"Rohde","year":"1976","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.bmc.2020.115837_b0065","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0026-895X(25)14414-3","article-title":"Antimalarial activity of selected aromatic chelators","volume":"18","author":"Scheibel","year":"1980","journal-title":"Mol Pharmacol."},{"key":"10.1016\/j.bmc.2020.115837_b0070","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/mmy\/myx003","article-title":"Evaluation of 8-hydroxyquinoline derivatives as hits for antifungal drug design","volume":"55","author":"Pippi","year":"2017","journal-title":"Med Mycol."},{"key":"10.1016\/j.bmc.2020.115837_b0075","first-page":"69","article-title":"The influence of chemical constitution of antibacterial activity; a study of 8-hydroxyquinolin (oxine) and related compounds","volume":"28","author":"Albert","year":"1947","journal-title":"Br J Exp Pathol."},{"key":"10.1016\/j.bmc.2020.115837_b0080","first-page":"119","article-title":"The influence of chemical constitution on antibacterial activity. VI. The bactericidal action of 8-hydroxyquinoline (oxine)","volume":"34","author":"Albert","year":"1953","journal-title":"Br J Exp Pathol."},{"key":"10.1016\/j.bmc.2020.115837_b0085","first-page":"75","article-title":"The influence of chemical constitution on anti-bacterial activity. VII. The site of action of 8-hydroxy-quinoline (oxine)","volume":"35","author":"Albert","year":"1954","journal-title":"Br J Exp Pathol."},{"key":"10.1016\/j.bmc.2020.115837_b0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-4362.1977.tb04317.x","article-title":"The halogenated 8-hydroxyquinolines","volume":"16","author":"Neldner","year":"1977","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.bmc.2020.115837_b0095","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02391-18","article-title":"Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance","volume":"9","author":"Bohlmann","year":"2018","journal-title":"mBio."},{"key":"10.1016\/j.bmc.2020.115837_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002357","article-title":"A molecular mechanism for bacterial susceptibility to zinc","volume":"7","author":"McDevitt","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bmc.2020.115837_b0105","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00048-18","article-title":"New Insights into the Role of Zinc Acquisition and Zinc Tolerance in Group A Streptococcal Infection","volume":"86","author":"Ong","year":"2018","journal-title":"Infect Immun."},{"key":"10.1016\/j.bmc.2020.115837_b0110","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1021\/ic0494051","article-title":"Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes","volume":"43","author":"Di Vaira","year":"2004","journal-title":"Inorg Chem."},{"key":"10.1016\/j.bmc.2020.115837_b0115","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ejic.201601120","article-title":"Structures of the Copper and Zinc Complexes of PBT2, a Chelating Agent Evaluated as Potential Drug for Neurodegenerative Diseases","volume":"2017","author":"Nguyen","year":"2017","journal-title":"Eur J Inorg Chem"},{"key":"10.1016\/j.bmc.2020.115837_b0120","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1021\/ac60256a013","article-title":"Tridentate ligands derived from substitution in the methyl group of 8-hydroxyquinaldine","volume":"39","author":"Stevenson","year":"1967","journal-title":"Anal Chem"},{"key":"10.1016\/j.bmc.2020.115837_b0125","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jinorgbio.2010.08.014","article-title":"Hydroxyquinoline based binders: promising ligands for chelatotherapy?","volume":"105","author":"Budimir","year":"2011","journal-title":"J Inorg Biochem."},{"key":"10.1016\/j.bmc.2020.115837_b0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bmc.2020.115837_b0135","doi-asserted-by":"crossref","first-page":"17670","DOI":"10.1074\/jbc.M602487200","article-title":"Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity","volume":"281","author":"White","year":"2006","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bmc.2020.115837_b0140","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00157-20","article-title":"Multiple Bactericidal Mechanisms of the Zinc Ionophore PBT2","volume":"5","author":"Harbison-Price","year":"2020","journal-title":"mSphere."},{"key":"10.1016\/j.bmc.2020.115837_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/aem.55.1.1-6.1989","article-title":"Effect of ionophores on ruminal fermentation","volume":"55","author":"Russell","year":"1989","journal-title":"Appl Environ Microbiol."},{"key":"10.1016\/j.bmc.2020.115837_b0150","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/jvp.12674","article-title":"Repurposing Ionophores as novel antimicrobial agents for the treatment of bovine mastitis caused by Gram-positive pathogens","volume":"41","author":"Hickey","year":"2018","journal-title":"J Vet Pharmacol Ther."},{"key":"10.1016\/j.bmc.2020.115837_b0155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/eva.12185","article-title":"Antibiotics in agriculture and the risk to human health: how worried should we be?","volume":"8","author":"Chang","year":"2015","journal-title":"Evol Appl."},{"key":"10.1016\/j.bmc.2020.115837_b0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-6445(03)00019-6","volume":"27","author":"Russell","year":"2003","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.bmc.2020.115837_b0165","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00433-19","article-title":"Unknown Risk on the Farm: Does Agricultural Use of Ionophores Contribute to the Burden of Antimicrobial Resistance?","volume":"4","author":"Wong","year":"2019","journal-title":"mSphere."},{"key":"10.1016\/j.bmc.2020.115837_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127110","article-title":"Substituted sulfonamide bioisosteres of 8-hydroxyquinoline as zinc-dependent antibacterial compounds","author":"McGowan","year":"2020","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmc.2020.115837_b0175","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10911-011-9236-y","article-title":"Molecular epidemiology of mastitis pathogens of dairy cattle and comparative relevance to humans","volume":"16","author":"Zadoks","year":"2011","journal-title":"J Mammary Gland Biol Neoplasia."},{"key":"10.1016\/j.bmc.2020.115837_b0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2885.1990.tb00774.x","article-title":"Bovine mastitis\u2013why does antibiotic therapy not always work? An overview","volume":"13","author":"Sandholm","year":"1990","journal-title":"J Vet Pharmacol Ther."},{"key":"10.1016\/j.bmc.2020.115837_b0185","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/00480169.1998.36094","article-title":"Efficacy of two antibiotic treatments in curing clinical and subclinical mastitis in lactating dairy cows","volume":"46","author":"McDougall","year":"1998","journal-title":"New Zealand Veterinary J."},{"key":"10.1016\/j.bmc.2020.115837_b0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4162\/nrp.2007.1.1.29","article-title":"Cellular Zn depletion by metal ion chelators (TPEN, DTPA and chelex resin) and its application to osteoblastic MC3T3-E1 cells","volume":"1","author":"Cho","year":"2007","journal-title":"Nutr Res Pract."},{"key":"10.1016\/j.bmc.2020.115837_b0195","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbamcr.2009.08.006","article-title":"To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition","volume":"1803","author":"Jacobsen","year":"2010","journal-title":"Biochim Biophys Acta."},{"key":"10.1016\/j.bmc.2020.115837_b0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejmech.2017.01.031","article-title":"Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands","volume":"128","author":"Rogolino","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115837_b0205","unstructured":"BS EN 1656:2009 Chemical disinfectants and antiseptics - quantitative suspension test for the evaluation of bactericidal activity of chemical disinfectants and antiseptics used in the veterinary area - test method and requirements (phase 2, step 1). London, UK: British Standards Institution; 2009."},{"key":"10.1016\/j.bmc.2020.115837_b0210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nature22308","article-title":"Predictive compound accumulation rules yield a broad-spectrum antibiotic","volume":"545","author":"Richter","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2020.115837_b0215","unstructured":"Brimble MA, Cook GM, Ferguson SA, Heikal A, Rennison D. PCT Int. Appl., 2019, WO 2019125185."}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620306672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620306672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:12:07Z","timestamp":1760836327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089620306672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":43,"alternative-id":["S0968089620306672"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115837","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-2 derivatized 8-sulfonamidoquinolines as antibacterial compounds","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115837"}}